Recent advancements in drug-eluting stents have improved metallic and resorbable structures, antiproliferative drugs, and polymers to minimize restenosis and thrombosis.
This review summarizes the evolution of coronary stents, including improvements in design, drugs, and polymers, and outlines ideal characteristics for future stents.
There has been a great evolution in the development of coronary stents in order to avoid both restenosis and thrombosis. Improvements have led to improvements in the design and conformation of metallic or resorbable structures, with an adequate balance between trackability and radial force, the development of antiproliferative drugs and the polymers to control release and allow adequate endothelialisation and an optimal duration of the antiplatelet regimen. Some suggestions are provided about the ideal characteristics of future coronary stents.
Lee et al. (Mon,) conducted a review in Coronary artery disease. Drug-eluting stents was evaluated. Recent advancements in drug-eluting stents have improved metallic and resorbable structures, antiproliferative drugs, and polymers to minimize restenosis and thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: